Overweight young men 'more likely to get severe liver disease'
Conclusion This cohort study aimed to assess whether a high BMI in late adolescence is associated with an increased risk of severe liver disease and liver cancer in later life. The researchers generally found a higher BMI was associated with an increased risk of severe liver disease, including liver cancer. A diagnosis of type 2 diabetes during follow-up was associated with a further increased risk of severe liver disease, regardless of BMI at the start of the study. This study included a very large population, and has used reliable sources of data for medical diagnoses and cause of death. But there are limitations to ...
Source: NHS News Feed - March 21, 2017 Category: Consumer Health News Tags: Obesity Cancer Source Type: news
Sequana Medical adds $9m for Alfapump implantable pump
Sequana Medical said today that it added $9.3 million to the $26 million Series C round it raised last year, as it readies for a U.S. clinical trial of its Alfapump implantable pump. Zurich-based Sequana said existing backers NeoMed Management, VI Partners, Biomed Invest, Capricorn Health-tech Fund, Entrepreneurs Fund and Life Science Partners put up $5.5 million. New investors Salus Partners and Quest for Growth put in another $3.8 million, the company said. Sequana won CE Mark approval in the European Union in 2011 for the Alfapump, a fully implantable pump designed to continu...
Source: Mass Device - October 23, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Clinical Trials Implants Sequana Medical AG Source Type: news
Grant will allow expansion of nurse-led paracentesis service
A nurse-led service, which has helped transform care for patients with chronic liver disease, has won a £10,000 award to develop its innovative work. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - September 17, 2015 Category: Nursing Source Type: news
What Treatment is Available for Lymphatic Malformations?
Discussion Vascular malformations including those of the arterial, venous and lymphatic systems are due to an arrest of the normal process of angiogenesis, vasculogenesis and remodeling of the vessels. They are not tumors and need to be differentiated from benign and malignant vascular lesions. They occur in 1.5% of the population with 90% present at birth. The nomenclature of congenital lymphatic malformations can be confusing. They can be present in any location and may have mixed elements within them (i.e. lymphatic and venous, lymphatic and arterial, etc.) and different structural components such as dilatation or hype...
Source: PediatricEducation.org - April 21, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news